全文获取类型
收费全文 | 1419501篇 |
免费 | 116324篇 |
国内免费 | 3384篇 |
专业分类
耳鼻咽喉 | 18492篇 |
儿科学 | 46818篇 |
妇产科学 | 41254篇 |
基础医学 | 202140篇 |
口腔科学 | 38067篇 |
临床医学 | 126934篇 |
内科学 | 286800篇 |
皮肤病学 | 33661篇 |
神经病学 | 118069篇 |
特种医学 | 54226篇 |
外国民族医学 | 467篇 |
外科学 | 212060篇 |
综合类 | 32824篇 |
现状与发展 | 3篇 |
一般理论 | 490篇 |
预防医学 | 110632篇 |
眼科学 | 31684篇 |
药学 | 99265篇 |
1篇 | |
中国医学 | 3372篇 |
肿瘤学 | 81950篇 |
出版年
2021年 | 11155篇 |
2019年 | 11890篇 |
2018年 | 16822篇 |
2017年 | 12839篇 |
2016年 | 14470篇 |
2015年 | 16260篇 |
2014年 | 22908篇 |
2013年 | 33828篇 |
2012年 | 46142篇 |
2011年 | 48684篇 |
2010年 | 28578篇 |
2009年 | 27401篇 |
2008年 | 44959篇 |
2007年 | 47415篇 |
2006年 | 47980篇 |
2005年 | 46439篇 |
2004年 | 44285篇 |
2003年 | 42164篇 |
2002年 | 40617篇 |
2001年 | 73271篇 |
2000年 | 74813篇 |
1999年 | 61791篇 |
1998年 | 17079篇 |
1997年 | 15507篇 |
1996年 | 15663篇 |
1995年 | 14872篇 |
1994年 | 13477篇 |
1993年 | 12640篇 |
1992年 | 46021篇 |
1991年 | 43631篇 |
1990年 | 41622篇 |
1989年 | 39664篇 |
1988年 | 36295篇 |
1987年 | 35446篇 |
1986年 | 32963篇 |
1985年 | 31372篇 |
1984年 | 23889篇 |
1983年 | 20072篇 |
1982年 | 12243篇 |
1981年 | 10814篇 |
1979年 | 20752篇 |
1978年 | 14606篇 |
1977年 | 12114篇 |
1976年 | 11382篇 |
1975年 | 11643篇 |
1974年 | 14027篇 |
1973年 | 13568篇 |
1972年 | 12681篇 |
1971年 | 11504篇 |
1970年 | 10942篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
151.
Del Lama Rafael Silva Candido Raquel Mariana Chiari-Correia Natália Santana Nogueira-Barbosa Marcello Henrique de Azevedo-Marques Paulo Mazzoncini Tinós Renato 《Journal of digital imaging》2022,35(3):446-458
Journal of Digital Imaging - Vertebral Compression Fracture (VCF) occurs when the vertebral body partially collapses under the action of compressive forces. Non-traumatic VCFs can be secondary to... 相似文献
152.
153.
154.
Victoria A. Chang Dawn M. Meyer Brett C. Meyer 《Journal of stroke and cerebrovascular diseases》2019,28(1):163-166
Background
Acute stroke codes may be activated for anisocoria, but how often these codes lead to a final stroke diagnosis or alteplase treatment is unknown. The purpose of this study was to assess the frequency of anisocoria in stroke codes that ultimately resulted in alteplase administration.Methods
We retrospectively assessed consecutive alteplase-treated patients from a prospectively-collected stroke registry between February 2015 and July 2018. Based on the stroke code exam, patients were categorized as having isolated anisocoria [A+(only)], anisocoria with other findings [A+(other)], or no anisocoria [A?]. Baseline demographics, stroke severity, alteplase time metrics, and outcomes were also collected.Results
Ninety-six patients received alteplase during the study period. Of the 94 who met inclusion criteria, there were 0 cases of A+(only). There were 9 cases of A+(other) (9.6%). A+(other) exhibited higher baseline National Institutes of Health (NIH) Stroke Scale scores compared to A? (17 versus 7; P?=?.0003), and no additional differences in demographics or alteplase time metrics. Final stroke diagnosis and other outcome measures were no different between A+(other) and A?. Of the A+ patients without pre-existing anisocoria, 5 of 6 (83%) had posterior circulation events or diffuse subarachnoid hemorrhage.Conclusions
In this exploratory analysis, zero patients with isolated anisocoria received alteplase treatment. Anisocoria as a part of the neurologic presentation occurred in 10% of alteplase patients, and was strongly associated with a posterior circulation event. Therefore, we conclude that anisocoria has a higher likelihood of leading to alteplase treatment when identified in the presence of other neurologic deficits. 相似文献155.
Ramya C. Mosarla Muthiah Vaduganathan Arman Qamar Javid Moslehi Gregory Piazza Robert P. Giugliano 《Journal of the American College of Cardiology》2019,73(11):1336-1349
Patients with active cancer are at an increased risk of arterial and venous thromboembolism (VTE) and bleeding events. Historically, in patients with cancer, low molecular weight heparins have been preferred for treatment of VTE, whereas warfarin has been the standard anticoagulant for stroke prevention in patients with atrial fibrillation (AF). More recently, direct oral anticoagulants (DOACs) have been demonstrated to reduce the risk of venous and arterial thromboembolism in large randomized clinical trials of patients with VTE and AF, respectively, thus providing an attractive oral dosing option that does not require routine laboratory monitoring. In this review, we summarize available clinical trial data and guideline recommendations, and outline a practical approach to anticoagulation management of VTE and AF in cancer. 相似文献
156.
157.
Toshiro Hara Rony Chanoch-Myers Nathan D. Mathewson Chad Myskiw Lyla Atta Lillian Bussema Stephen W. Eichhorn Alissa C. Greenwald Gabriela S. Kinker Christopher Rodman L. Nicolas Gonzalez Castro Hiroaki Wakimoto Orit Rozenblatt-Rosen Xiaowei Zhuang Jean Fan Tony Hunter Inder M. Verma Kai W. Wucherpfennig Itay Tirosh 《Cancer cell》2021,39(6):779-792.e11
158.
159.
160.